CorMedix Inc. – NASDAQ:CRMD

CorMedix stock price today

$13.06
+4.85
+59.07%
Financial Health
0
1
2
3
4
5
6
7
8
9

CorMedix stock price monthly change

+71.76%
month

CorMedix stock price quarterly change

+71.76%
quarter

CorMedix stock price yearly change

+110.51%
year

CorMedix key metrics

Market Cap
499.37M
Enterprise value
167.95M
P/E
-6.62
EV/Sales
2567.86
EV/EBITDA
-5.56
Price/Sales
3218.73
Price/Book
3.82
PEG ratio
-4.96
EPS
-0.93
Revenue
N/A
EBITDA
-53.75M
Income
-50.23M
Revenue Q/Q
N/A
Revenue Y/Y
426.39%
Profit margin
-45409.9%
Oper. margin
-46819.91%
Gross margin
94.29%
EBIT margin
-46819.91%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CorMedix stock price history

CorMedix stock forecast

CorMedix financial statements

CorMedix Inc. (NASDAQ:CRMD): Profit margin
Jun 2023 0 -11.27M
Sep 2023 0 -9.74M
Dec 2023 304.11K -14.75M -4851.54%
Mar 2024 0 -14.46M
CorMedix Inc. (NASDAQ:CRMD): Analyst Estimates
Dec 2023 304.11K -14.75M -4851.54%
Mar 2024 0 -14.46M
Oct 2025 18M -2.87M -15.97%
Dec 2025 21.95M -1.15M -5.24%
  • Analysts Price target

  • Financials & Ratios estimates

CorMedix Inc. (NASDAQ:CRMD): Debt to assets
Jun 2023 57032780 7.98M 13.99%
Sep 2023 91429120 8.22M 9%
Dec 2023 82059957 11.91M 14.52%
Mar 2024 68023742 10.01M 14.72%
CorMedix Inc. (NASDAQ:CRMD): Cash Flow
Jun 2023 -8.57M -2.38M 5.35M
Sep 2023 -8.69M -586.86K 42.89M
Dec 2023 -10.74M 597.79K 467.65K
Mar 2024 -17.31M 8.94M -97.11K

CorMedix alternative data

CorMedix Inc. (NASDAQ:CRMD): Employee count
Aug 2023 40
Sep 2023 40
Oct 2023 40
Nov 2023 40
Dec 2023 40
Jan 2024 40
Feb 2024 40
Mar 2024 40
Apr 2024 40
May 2024 40
Jun 2024 82
Jul 2024 82

CorMedix other data

4.58% -23.06%
of CRMD is owned by hedge funds
1.84M -9.54M
shares is hold by hedge funds

CorMedix Inc. (NASDAQ:CRMD): Insider trades (number of shares)
Period Buy Sel
Dec 2023 6000 0
Mar 2024 13561 0
Nov 2024 0 140027
Transaction Date Insider Security Shares Price per share Total value Source
Option
ZELNICK KAUFMAN BETH officer: Chief Legal Officer
Common Stock 12,500 N/A N/A
Option
ZELNICK KAUFMAN BETH officer: Chief Legal Officer
Restricted Stock Units 12,500 N/A N/A
Option
HURLBURT ELIZABETH officer: EVP Stock Option (Right to Buy Common Stock) 3 $1.45 $4
Option
HURLBURT ELIZABETH officer: EVP Common Stock 8,169 $8.3 $67,803
Option
HURLBURT ELIZABETH officer: EVP Common Stock 3 $1.45 $4
Sale
HURLBURT ELIZABETH officer: EVP Common Stock 140,027 $11.18 $1,565,642
Option
HURLBURT ELIZABETH officer: EVP Stock Option (Right to Buy Common Stock) 9,888 $5.63 $55,669
Option
HURLBURT ELIZABETH officer: EVP Stock Option (Right to Buy Common Stock) 8,169 $8.3 $67,803
Option
HURLBURT ELIZABETH officer: EVP Stock Option (Right to Buy Common Stock) 34,467 $4.08 $140,625
Option
HURLBURT ELIZABETH officer: EVP Common Stock 25,000 $3.47 $86,750
Patent
Application
Filling date: 19 May 2020 Issue date: 1 Apr 2021
Application
Filling date: 5 Oct 2020 Issue date: 25 Mar 2021
Application
Filling date: 31 Dec 2019 Issue date: 17 Dec 2020
Application
Filling date: 13 Jun 2019 Issue date: 30 Jan 2020
Grant
Filling date: 18 Aug 2016 Issue date: 31 Dec 2019
Application
Filling date: 3 Sep 2019 Issue date: 19 Dec 2019
Application
Filling date: 28 Aug 2019 Issue date: 19 Dec 2019
Application
Filling date: 28 Aug 2019 Issue date: 19 Dec 2019
Grant
Filling date: 28 Mar 2017 Issue date: 19 Nov 2019
Friday, 27 December 2024
zacks.com
Thursday, 19 December 2024
globenewswire.com
Tuesday, 26 November 2024
globenewswire.com
Friday, 8 November 2024
zacks.com
zacks.com
seekingalpha.com
zacks.com
Monday, 4 November 2024
zacks.com
globenewswire.com
Wednesday, 30 October 2024
seekingalpha.com
zacks.com
globenewswire.com
Monday, 28 October 2024
seekingalpha.com
Friday, 25 October 2024
seekingalpha.com
Thursday, 24 October 2024
globenewswire.com
Wednesday, 23 October 2024
globenewswire.com
Friday, 13 September 2024
globenewswire.com
Monday, 9 September 2024
zacks.com
globenewswire.com
Thursday, 5 September 2024
zacks.com
zacks.com
Tuesday, 20 August 2024
zacks.com
Wednesday, 14 August 2024
seekingalpha.com
zacks.com
globenewswire.com
Wednesday, 7 August 2024
globenewswire.com
Wednesday, 3 July 2024
globenewswire.com
Thursday, 6 June 2024
globenewswire.com
Tuesday, 28 May 2024
globenewswire.com
Saturday, 11 May 2024
Seeking Alpha
  • What's the price of CorMedix stock today?

    One share of CorMedix stock can currently be purchased for approximately $13.06.

  • When is CorMedix's next earnings date?

    Unfortunately, CorMedix's (CRMD) next earnings date is currently unknown.

  • Does CorMedix pay dividends?

    No, CorMedix does not pay dividends.

  • How much money does CorMedix make?

    CorMedix has a market capitalization of 499.37M.

  • What is CorMedix's stock symbol?

    CorMedix Inc. is traded on the NASDAQ under the ticker symbol "CRMD".

  • What is CorMedix's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of CorMedix?

    Shares of CorMedix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are CorMedix's key executives?

    CorMedix's management team includes the following people:

    • Dr. Phoebe Mounts Esq. Executive Vice President, Gen. Counsel, Sec. and Head of Regulatory, Compliance & Legal(age: 75, pay: $523,080)
    • Ms. Elizabeth Masson-Hurlburt Executive Vice President & Head of Clinical Operations(age: 46, pay: $463,850)
    • Dr. Matthew T. David M.D. Interim Chief Executive Officer, Executive Vice President & Chief Financial Officer(age: 47, pay: $441,960)
  • How many employees does CorMedix have?

    As Jul 2024, CorMedix employs 82 workers, which is 105% more then previous quarter.

  • When CorMedix went public?

    CorMedix Inc. is publicly traded company for more then 15 years since IPO on 13 May 2010.

  • What is CorMedix's official website?

    The official website for CorMedix is cormedix.com.

  • Where are CorMedix's headquarters?

    CorMedix is headquartered at 300 Connell Drive, Berkeley Heights, NJ.

  • How can i contact CorMedix?

    CorMedix's mailing address is 300 Connell Drive, Berkeley Heights, NJ and company can be reached via phone at +90 85179500.

CorMedix company profile:

CorMedix Inc.

cormedix.com
Exchange:

NASDAQ

Full time employees:

82

Industry:

Biotechnology

Sector:

Healthcare

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

300 Connell Drive
Berkeley Heights, NJ 07922

CIK: 0001410098
ISIN: US21900C3088
CUSIP: 21900C308